Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.74 USD | -4.20% |
|
-11.45% | -11.27% |
Capitalization | 576M 556M 525M 463M 824M 49.96B 914M 6.25B 2.32B 20.76B 2.16B 2.11B 87.66B | P/E ratio 2024 * |
-4.25x | P/E ratio 2025 * | -4.81x |
---|---|---|---|---|---|
Enterprise value | 276M 267M 252M 222M 395M 23.93B 438M 3B 1.11B 9.94B 1.03B 1.01B 42B | EV / Sales 2024 * |
-
| EV / Sales 2025 * | - |
Free-Float |
93.46% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Rapport Therapeutics, Inc.
1 day | -4.20% | ||
1 week | -11.45% | ||
Current month | -4.08% | ||
1 month | +6.28% | ||
3 months | -41.49% | ||
6 months | -17.42% | ||
Current year | -11.27% |







Director | Title | Age | Since |
---|---|---|---|
David Bredt
CTO | Chief Tech/Sci/R&D Officer | 60 | 2022-12-31 |
Abraham Ceesay
CEO | Chief Executive Officer | 47 | 2023-01-31 |
Troy Ignelzi
DFI | Director of Finance/CFO | 57 | 2023-10-31 |
Manager | Title | Age | Since |
---|---|---|---|
James Healy
BRD | Director/Board Member | 60 | 2023-08-22 |
Abraham Ceesay
BRD | Director/Board Member | 47 | 2023-02-28 |
Reid Huber
BRD | Director/Board Member | 53 | 2022-01-31 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-4.20% | -11.45% | - | - | 601M | ||
+0.59% | +0.46% | +36.99% | -0.85% | 48.01B | ||
-2.94% | +0.42% | -7.93% | -17.76% | 36.45B | ||
+0.39% | +1.30% | +5.06% | +23.81% | 26.18B | ||
-1.83% | -3.06% | -32.72% | -28.37% | 15.76B | ||
+2.22% | -0.03% | +66.39% | +73.56% | 15.43B | ||
-2.95% | -9.48% | -64.62% | -80.83% | 12.26B | ||
-2.25% | -5.80% | +0.57% | -34.69% | 11.05B | ||
-7.52% | -5.51% | +0.45% | +87.46% | 10.99B | ||
+4.17% | +15.13% | - | - | 10.76B | ||
Average | -1.48% | -1.93% | +0.52% | +2.79% | 18.75B | |
Weighted average by Cap. | -0.89% | +0.13% | +7.65% | +1.19% |
2024 * | 2025 * | |
---|---|---|
Net sales | - | - |
Net income | -81.73M -78.99M -74.57M -65.79M -117M -7.09B -130M -888M -329M -2.95B -306M -300M -12.44B | -129M -125M -118M -104M -185M -11.23B -205M -1.41B -522M -4.66B -485M -475M -19.7B |
Net Debt | -300M -290M -274M -241M -429M -26.02B -476M -3.26B -1.21B -10.81B -1.12B -1.1B -45.66B | -378M -365M -345M -304M -541M -32.81B -600M -4.11B -1.52B -13.63B -1.42B -1.39B -57.57B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-11 | 15.74 $ | -4.20% | 116,029 |
25-02-10 | 16.43 $ | +1.86% | 58,252 |
25-02-07 | 16.13 $ | -3.70% | 113,071 |
25-02-06 | 16.75 $ | -4.56% | 69,615 |
25-02-05 | 17.55 $ | -1.27% | 65,928 |
Delayed Quote Nasdaq, February 11, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RAPP Stock